| IL-2 (ng/ml) | INF-γ (ng/ml) | ||||
---|---|---|---|---|---|---|
Treatment | Pre-challenge | 2 days post-challenge | 7 days post-challenge | Pre-challenge | 2 days post-challenge | 7 days post-challenge |
T1 †| 7.9 ± 1.0a | 7.2 ± 0.7b | 5.8 ± 1.7 | 5.7 ± 1.0a | 7.9 ± 1.3 | 5.3 ± 1.9 |
T2 | 2.9 ± 0.7b | 5.1 ± 1.5b | 6.8 ± 1.0 | 2.1 ± 0.7b | 6.9 ± 0.9 | 5.7 ± 1.1 |
T3 | 6.5 ± 1.2a | 6.3 ± 0.6b | 4.5 ± 1.3 | 3.6 ± 0.7ab | 7.4 ± 2.0 | 4.4 ± 1.6 |
T4 | 8.4 ± 0.9a | 10.6 ± 1.0a | 5.3 ± 0.6 | 6.2 ± 0.9a | 7.7 ± 1.9 | 5.8 ± 1.9 |